Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data
Background Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) hav...
Uloženo v:
| Vydáno v: | Journal of nanobiotechnology Ročník 17; číslo 1; s. 61 - 14 |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
London
BioMed Central
13.05.2019
BioMed Central Ltd Springer Nature B.V BMC |
| Témata: | |
| ISSN: | 1477-3155, 1477-3155 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Background
Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs.
Results
Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging.
Conclusions
Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. |
|---|---|
| AbstractList | Background Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs. Results Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging. Conclusions Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. Background Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs. Results Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging. Conclusions Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. Abstract Background Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs. Results Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging. Conclusions Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs. Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging. Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs.BACKGROUNDProtein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs.Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging.RESULTSApproximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging.Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs.CONCLUSIONSCompared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and drug delivery agents. Virus-like particles (VLPs) derived from the single-stranded RNA (ssRNA) bacteriophage coat proteins (CPs) have been important and successful contenders in the area due to their simplicity and robustness. However, only a few different VLP types are available that put certain limitations on continued developments and expanded adaptation of ssRNA phage VLP technology. Metagenomic studies have been a rich source for discovering novel viral sequences, and in recent years have unraveled numerous ssRNA phage genomes significantly different from those known before. Here, we describe the use of ssRNA CP sequences found in metagenomic data to experimentally produce and characterize novel VLPs. Approximately 150 ssRNA phage CP sequences were sourced from metagenomic sequence data and grouped into 14 different clusters based on CP sequence similarity analysis. 110 CP-encoding sequences were obtained by gene synthesis and expressed in bacteria which in 80 cases resulted in VLP assembly. Production and purification of the VLPs was straightforward and compatible with established protocols, with the only exception that a considerable proportion of the CPs had to be produced at a lower temperature to ensure VLP assembly. The VLP morphology was similar to that of the previously studied phages, although a few deviations such as elongated or smaller particles were noted in certain cases. In addition, stabilizing inter-subunit disulfide bonds were detected in six VLPs and several possible candidate RNA structures in the phage genomes were identified that might bind to the coat protein and ensure specific RNA packaging. Compared to the few types of ssRNA phage VLPs that were used before, several dozens of new particles representing ten distinct similarity groups are now available with a notable potential for biotechnological applications. It is believed that the novel VLPs described in this paper will provide the groundwork for future development of new vaccines and other applications based on ssRNA bacteriophage VLPs. |
| ArticleNumber | 61 |
| Audience | Academic |
| Author | Liekniņa, Ilva Šišovs, Mihails Jansons, Juris Tārs, Kaspars Akopjana, Ināra Bogans, Jānis Kalniņš, Gints Rūmnieks, Jānis |
| Author_xml | – sequence: 1 givenname: Ilva surname: Liekniņa fullname: Liekniņa, Ilva organization: Latvian Biomedical Research and Study Center – sequence: 2 givenname: Gints surname: Kalniņš fullname: Kalniņš, Gints organization: Latvian Biomedical Research and Study Center – sequence: 3 givenname: Ināra surname: Akopjana fullname: Akopjana, Ināra organization: Latvian Biomedical Research and Study Center – sequence: 4 givenname: Jānis surname: Bogans fullname: Bogans, Jānis organization: Latvian Biomedical Research and Study Center – sequence: 5 givenname: Mihails surname: Šišovs fullname: Šišovs, Mihails organization: Latvian Biomedical Research and Study Center – sequence: 6 givenname: Juris surname: Jansons fullname: Jansons, Juris organization: Latvian Biomedical Research and Study Center – sequence: 7 givenname: Jānis surname: Rūmnieks fullname: Rūmnieks, Jānis organization: Latvian Biomedical Research and Study Center – sequence: 8 givenname: Kaspars orcidid: 0000-0001-8421-9023 surname: Tārs fullname: Tārs, Kaspars email: kaspars@biomed.lu.lv organization: Latvian Biomedical Research and Study Center |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31084612$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wA9igSGxgkeJXbGeDNKp4jFQBKrC2HOcm4yGxBzsZAb8eTzO0nQpQFo7u_c6xfX1OsyPnHWTZU4zOMZb8VcSkKnGBcFUgVolCPshOMBOioLgsj-78H2enMa4RIoQR9ig7phhJxjE5ycKn4JvJjNa7XLsmNysdtBkh2F_6uujb3Pkt9HmMVx8WeT03_WalO8i3Nkyx6O03yDc6jNb0EPM2-CEfYEyA84M1eYTvEzhjXZc3etSPs4et7iM82a9n2de3b75cvC8uP75bXiwuC8OpGAvDJJNSVDUStG4Q8JJXmlctxqldm5IC4lQzoSk3ZW0Ekq0wwAhlSDQSOD3LlrNv4_VabYIddPipvLbquuBDp_ZnVrStADQ3rOEl4w2ShlGiOdPMANFs5_V69tpM9QCNATcG3R-YHnacXanObxUvMS0JSwYv9gbBp2nEUQ02Guh77cBPURFCCSKYoh36_B669lNwaVSJIgJLzCi-pTqdLmBd69O-ZmeqFqUsKRcVrhJ1_hcqfQ2kl0lpam2qHwheHggSM8KPsdNTjGr5-eqQfXZ3KDfT-JOuBOAZMMHHGKC9QTBSuwSrOcEqJVjtEqxk0oh7GmPH6yimk9v-v0oyK2PaxXUQbuf2b9Fv1NYDeA |
| CitedBy_id | crossref_primary_10_1099_mgen_0_000369 crossref_primary_10_1002_wnan_1587 crossref_primary_10_1016_j_mib_2024_102555 crossref_primary_10_1016_j_vaccine_2020_07_016 crossref_primary_10_3390_v15101985 crossref_primary_10_3390_v14020225 crossref_primary_10_3390_ph14080764 crossref_primary_10_1111_all_15704 crossref_primary_10_3390_v12020185 crossref_primary_10_3390_v13071215 crossref_primary_10_3390_vaccines12091033 crossref_primary_10_1016_j_aqrep_2024_102450 crossref_primary_10_1016_j_copbio_2021_09_012 |
| Cites_doi | 10.1016/j.jmb.2016.08.025 10.1016/j.coviro.2018.07.003 10.1093/nar/18.22.6587 10.1016/j.jmb.2008.08.060 10.1128/JVI.6.6.847-854.1970 10.1016/0378-1119(93)90261-Z 10.1016/S1097-2765(00)80143-4 10.1186/1471-2180-12-277 10.1016/S0042-6822(95)80078-6 10.1006/viro.1998.9279 10.1016/j.jmb.2013.08.025 10.1038/nsmb1327 10.1016/0378-1119(83)90015-X 10.1016/j.jmb.2008.04.049 10.1016/j.jaci.2012.12.1561 10.1016/S0969-2126(96)00060-3 10.1128/JVI.02256-10 10.1007/978-981-10-8456-0_13 10.1099/0022-1317-83-6-1523 10.1016/j.jmb.2017.01.012 10.1016/j.vaccine.2015.05.016 10.1186/1743-422X-7-146 10.1371/journal.pone.0002547 10.1128/genomeA.00652-15 10.1038/371623a0 10.1159/000449503 10.1128/JB.00929-12 10.1016/S0140-6736(08)60381-5 10.1016/S0021-9258(19)39417-7 10.1038/ncomms12524 10.1107/S0907444912047464 10.1371/journal.pbio.1002409 10.1186/1471-2105-10-421 10.1038/nature20589 10.1038/nature20167 10.1038/237082a0 10.1073/pnas.1609482113 10.1006/viro.2000.0373 10.1002/btm2.10049 10.1016/j.jmb.2009.06.047 10.1128/JVI.01005-06 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2019 COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION NPM ISR 3V. 7QO 7TB 7X7 7XB 88E 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AFKRA AZQEC BBNVY BENPR BGLVJ BHPHI CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ HCIFZ K9. KB. LK8 M0S M1P M7P P64 PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12951-019-0497-8 |
| DatabaseName | Springer Nature Open Access Journals CrossRef PubMed Gale In Context: Science ProQuest Central (Corporate) Biotechnology Research Abstracts Mechanical & Transportation Engineering Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Journals Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Technology collection Natural Science Collection ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Biological Sciences ProQuest Health & Medical Collection PML(ProQuest Medical Library) Biological Science Database Biotechnology and BioEngineering Abstracts Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Mechanical & Transportation Engineering Abstracts ProQuest Central Essentials Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection Materials Science Database ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Materials Science Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Materials Science & Engineering Collection Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database PubMed |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: KB. name: Materials Science Database url: http://search.proquest.com/materialsscijournals sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering Chemistry |
| EISSN | 1477-3155 |
| EndPage | 14 |
| ExternalDocumentID | oai_doaj_org_article_3f9eea6c4d6546d08c432a64a4ce2a46 PMC6513524 A585367919 31084612 10_1186_s12951_019_0497_8 |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: European Research and Development Fund grantid: 1.1.1.1/16/A/104 – fundername: ; grantid: 1.1.1.1/16/A/104 |
| GroupedDBID | --- 0R~ 29L 2WC 53G 5VS 7X7 88E 8FE 8FG 8FH 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABJCF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADDVE ADMLS ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BBNVY BCNDV BENPR BFQNJ BGLVJ BHPHI BMC BPHCQ BVXVI C6C CCPQU CS3 D1I DIK DU5 E3Z EBD EBLON EBS EJD EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE I-F IAO IHR INH INR ISR ITC ITG ITH KB. KQ8 LK8 M1P M48 M7P MM. M~E O5R O5S OK1 OVT P2P PDBOC PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV RVI SCM SOJ SV3 TR2 TUS UKHRP WOQ WOW XSB ~8M AAYXX AFFHD CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 FRP NPM 7QO 7TB 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ K9. P64 PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c637t-c4848879b073bd0e6569a69f11637bc53e063a47a36c5bc708f7ce423407d8e63 |
| IEDL.DBID | M7P |
| ISICitedReferencesCount | 17 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000468053400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-3155 |
| IngestDate | Fri Oct 03 12:44:11 EDT 2025 Tue Nov 04 02:01:15 EST 2025 Thu Sep 04 17:07:49 EDT 2025 Sun Oct 19 00:04:54 EDT 2025 Tue Nov 11 10:36:23 EST 2025 Tue Nov 04 18:09:35 EST 2025 Thu Nov 13 14:15:07 EST 2025 Wed Feb 19 02:32:12 EST 2025 Tue Nov 18 22:09:21 EST 2025 Sat Nov 29 02:43:03 EST 2025 Sat Sep 06 07:34:59 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c637t-c4848879b073bd0e6569a69f11637bc53e063a47a36c5bc708f7ce423407d8e63 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0001-8421-9023 |
| OpenAccessLink | https://www.proquest.com/docview/2227181431?pq-origsite=%requestingapplication% |
| PMID | 31084612 |
| PQID | 2227181431 |
| PQPubID | 44676 |
| PageCount | 14 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_3f9eea6c4d6546d08c432a64a4ce2a46 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6513524 proquest_miscellaneous_2232021304 proquest_journals_2227181431 gale_infotracmisc_A585367919 gale_infotracacademiconefile_A585367919 gale_incontextgauss_ISR_A585367919 pubmed_primary_31084612 crossref_primary_10_1186_s12951_019_0497_8 crossref_citationtrail_10_1186_s12951_019_0497_8 springer_journals_10_1186_s12951_019_0497_8 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-05-13 |
| PublicationDateYYYYMMDD | 2019-05-13 |
| PublicationDate_xml | – month: 05 year: 2019 text: 2019-05-13 day: 13 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Journal of nanobiotechnology |
| PublicationTitleAbbrev | J Nanobiotechnol |
| PublicationTitleAlternate | J Nanobiotechnology |
| PublicationYear | 2019 |
| Publisher | BioMed Central BioMed Central Ltd Springer Nature B.V BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: Springer Nature B.V – name: BMC |
| References | RI Koning (497_CR38) 2016; 7 S Kannoly (497_CR22) 2012; 194 R Twarock (497_CR42) 2018; 31 J Rumnieks (497_CR21) 2012; 12 KM Beeh (497_CR6) 2013; 131 P Pumpens (497_CR10) 2016; 59 KV Gorzelnik (497_CR40) 2016; 113 M Persson (497_CR26) 2008; 383 497_CR45 A Kazaks (497_CR17) 2011; 85 P Plevka (497_CR27) 2009; 391 497_CR44 E Tumban (497_CR8) 2015; 33 TM Kozlovska (497_CR4) 1993; 137 J Rumnieks (497_CR35) 2014; 426 X Dai (497_CR39) 2017; 541 J Rumnieks (497_CR41) 2017; 429 JA Chao (497_CR36) 2008; 15 G Spohn (497_CR9) 2010; 7 J Klovins (497_CR16) 2002; 83 W Min Jou (497_CR24) 1972; 237 MJ Rohovie (497_CR11) 2017; 2 M Persson (497_CR34) 2013; 69 DS Peabody (497_CR12) 2008; 380 TM Ruokoranta (497_CR23) 2006; 80 K Valegård (497_CR33) 1994; 371 VJ Bardwell (497_CR13) 1990; 18 BP Tsai (497_CR14) 2011; 10 RA Kastelein (497_CR1) 1983; 23 R Golmohammadi (497_CR28) 1996; 4 K Tars (497_CR29) 2000; 272 C Axblom (497_CR31) 1998; 249 I Bendis (497_CR37) 1970; 6 J Rumnieks (497_CR32) 2018; 88 TM Kozlovskaya (497_CR3) 1986; 287 C Camacho (497_CR43) 2009; 10 AL Greninger (497_CR18) 2015; 3 DS Peabody (497_CR2) 1990; 265 E Bertrand (497_CR15) 1998; 2 RCL Olsthoorn (497_CR25) 1995; 206 M Shishovs (497_CR30) 2016; 428 AC Tissot (497_CR5) 2008; 371 SR Krishnamurthy (497_CR19) 2016; 14 J Cornuz (497_CR7) 2008; 3 M Shi (497_CR20) 2016; 540 |
| References_xml | – volume: 428 start-page: 4267 year: 2016 ident: 497_CR30 publication-title: J Mol Biol doi: 10.1016/j.jmb.2016.08.025 – volume: 31 start-page: 74 year: 2018 ident: 497_CR42 publication-title: Curr Opin Virol doi: 10.1016/j.coviro.2018.07.003 – volume: 18 start-page: 6587 year: 1990 ident: 497_CR13 publication-title: Nucleic Acids Res doi: 10.1093/nar/18.22.6587 – volume: 383 start-page: 914 year: 2008 ident: 497_CR26 publication-title: J Mol Biol doi: 10.1016/j.jmb.2008.08.060 – volume: 287 start-page: 452 year: 1986 ident: 497_CR3 publication-title: Dokl Akad Nauk SSSR – volume: 6 start-page: 847 year: 1970 ident: 497_CR37 publication-title: J Virol doi: 10.1128/JVI.6.6.847-854.1970 – volume: 137 start-page: 133 year: 1993 ident: 497_CR4 publication-title: Gene doi: 10.1016/0378-1119(93)90261-Z – volume: 2 start-page: 437 year: 1998 ident: 497_CR15 publication-title: Mol Cell doi: 10.1016/S1097-2765(00)80143-4 – volume: 12 start-page: 277 year: 2012 ident: 497_CR21 publication-title: BMC Microbiol doi: 10.1186/1471-2180-12-277 – volume: 206 start-page: 611 year: 1995 ident: 497_CR25 publication-title: Virology doi: 10.1016/S0042-6822(95)80078-6 – volume: 249 start-page: 80 year: 1998 ident: 497_CR31 publication-title: Virology doi: 10.1006/viro.1998.9279 – volume: 426 start-page: 1039 year: 2014 ident: 497_CR35 publication-title: J Mol Biol doi: 10.1016/j.jmb.2013.08.025 – volume: 15 start-page: 103 year: 2008 ident: 497_CR36 publication-title: Nat Struct Mol Biol doi: 10.1038/nsmb1327 – ident: 497_CR45 – volume: 23 start-page: 245 year: 1983 ident: 497_CR1 publication-title: Gene doi: 10.1016/0378-1119(83)90015-X – volume: 380 start-page: 252 year: 2008 ident: 497_CR12 publication-title: J Mol Biol doi: 10.1016/j.jmb.2008.04.049 – volume: 131 start-page: 866 year: 2013 ident: 497_CR6 publication-title: J Allergy Clin Immunol doi: 10.1016/j.jaci.2012.12.1561 – volume: 4 start-page: 543 year: 1996 ident: 497_CR28 publication-title: Structure doi: 10.1016/S0969-2126(96)00060-3 – volume: 85 start-page: 4628 year: 2011 ident: 497_CR17 publication-title: J Virol doi: 10.1128/JVI.02256-10 – volume: 88 start-page: 281 year: 2018 ident: 497_CR32 publication-title: Subcell Biochem doi: 10.1007/978-981-10-8456-0_13 – volume: 83 start-page: 1523 year: 2002 ident: 497_CR16 publication-title: J Gen Virol doi: 10.1099/0022-1317-83-6-1523 – volume: 429 start-page: 688 year: 2017 ident: 497_CR41 publication-title: J Mol Biol doi: 10.1016/j.jmb.2017.01.012 – volume: 33 start-page: 3346 year: 2015 ident: 497_CR8 publication-title: Vaccine doi: 10.1016/j.vaccine.2015.05.016 – volume: 7 start-page: 146 year: 2010 ident: 497_CR9 publication-title: Virol J doi: 10.1186/1743-422X-7-146 – volume: 3 start-page: e2547 year: 2008 ident: 497_CR7 publication-title: PLoS ONE doi: 10.1371/journal.pone.0002547 – volume: 3 start-page: e00652-15 year: 2015 ident: 497_CR18 publication-title: Genome Announc doi: 10.1128/genomeA.00652-15 – volume: 371 start-page: 623 year: 1994 ident: 497_CR33 publication-title: Nature doi: 10.1038/371623a0 – volume: 59 start-page: 74 year: 2016 ident: 497_CR10 publication-title: Intervirology doi: 10.1159/000449503 – volume: 194 start-page: 5073 year: 2012 ident: 497_CR22 publication-title: J Bacteriol doi: 10.1128/JB.00929-12 – volume: 371 start-page: 821 year: 2008 ident: 497_CR5 publication-title: Lancet doi: 10.1016/S0140-6736(08)60381-5 – volume: 265 start-page: 5684 year: 1990 ident: 497_CR2 publication-title: J Biol Chem doi: 10.1016/S0021-9258(19)39417-7 – volume: 10 start-page: 007385 issue: M110 year: 2011 ident: 497_CR14 publication-title: Mol Cell Proteomics – volume: 7 start-page: 12524 year: 2016 ident: 497_CR38 publication-title: Nat Commun doi: 10.1038/ncomms12524 – volume: 69 start-page: 367 year: 2013 ident: 497_CR34 publication-title: Acta Crystallogr D Biol Crystallogr doi: 10.1107/S0907444912047464 – ident: 497_CR44 – volume: 14 start-page: e1002409 year: 2016 ident: 497_CR19 publication-title: PLoS Biol doi: 10.1371/journal.pbio.1002409 – volume: 10 start-page: 421 year: 2009 ident: 497_CR43 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-10-421 – volume: 541 start-page: 112 year: 2017 ident: 497_CR39 publication-title: Nature doi: 10.1038/nature20589 – volume: 540 start-page: 539 year: 2016 ident: 497_CR20 publication-title: Nature doi: 10.1038/nature20167 – volume: 237 start-page: 82 year: 1972 ident: 497_CR24 publication-title: Nature doi: 10.1038/237082a0 – volume: 113 start-page: 11519 year: 2016 ident: 497_CR40 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1609482113 – volume: 272 start-page: 331 year: 2000 ident: 497_CR29 publication-title: Virology doi: 10.1006/viro.2000.0373 – volume: 2 start-page: 43 year: 2017 ident: 497_CR11 publication-title: Bioeng Transl Med doi: 10.1002/btm2.10049 – volume: 391 start-page: 635 year: 2009 ident: 497_CR27 publication-title: J Mol Biol doi: 10.1016/j.jmb.2009.06.047 – volume: 80 start-page: 9326 year: 2006 ident: 497_CR23 publication-title: J Virol doi: 10.1128/JVI.01005-06 |
| SSID | ssj0022424 |
| Score | 2.2795582 |
| Snippet | Background
Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted... Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted bioimaging and... Background Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as targeted... Abstract Background Protein shells assembled from viral coat proteins are an attractive platform for development of new vaccines and other tools such as... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 61 |
| SubjectTerms | Assembly Bacteria Bacterial proteins Biotechnology Bonds (Securities) Chemistry Chemistry and Materials Science Coat protein Crystal structure Disulfide bonds Drug delivery Drug delivery systems Gene sequencing Genes Genomes Genomics Health aspects Medical imaging Molecular Medicine Morphology Nanotechnology Packaging Peptides Phages Product development Protein binding Proteins Ribonucleic acid RNA RNA phages RNA sequencing Similarity Technology Vaccines Viral vaccines Virology Virus-like particles Viruses West Nile virus |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3di9QwEA9y-KAP4rf1TokiCEq5pk3T5nEVDwVZjvODewvTNPWKe-2y3d2__2badN2eqC--NtOvyUzyGzLzG8ZeWWXTSkEaWtAqlBBDCJWAELFIIcocN_S-W8P3z9l8np-f69O9Vl-UEzbQAw-KO04q7RwoK0squymj3MokBiVBUisr2ZNtI-oZgykfalHRgz_DFLk67nBXSylspoMAjcvyZBfqyfp_X5L39qTr-ZLXDk37vejkLrvjQSSfDR9_j91wzX12e49a8AFbnQ5Urqh2Dk3J7Y6Yeai75G3Fm3brFrzrzuYzXgyD7fICFxi-rVebLlzUPx1fjqlznCpR-KVbA_G6XtaW-zRsfB-nRNOH7NvJh6_vP4a-v0JoVZKtQytzdN9MF-jmRRk5hHYalK4EYrSssGniEL-AzCDBCS1sFuVVZh3iLwwCy9yp5BE7aNrGPWFcINDL0PtLqKx0KgZQlY6kAIz3rE6jgEWjvo315OPUA2Nh-iAkV2aYIoNTZGiKTB6wN7tblgPzxt-E39Ek7gSJNLu_gKZkvJ7Mv0wpYC_JBAzRYjSUd_MDNl1nPn05MzOMqhKVaaED9toLVS3-gQVfxoB6ICatieTRRBL91k6HR0szft3oDFUmI-ZCVBewF7thupNy4RrXbkiGet4j9pABezwY5u6_EawjoBRxwLKJyU4UMx1p6oueVVylAsE4PvPtaNy_PuuPen_6P_R-yG7FvWumoUiO2MF6tXHP2E27Xdfd6nnv2FedHlDS priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLINK Contemporary 1997-Present dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwEB5BQQIeOMoVKMggJCSqiByOEz8uFRVIaFVtoeqb5ThOG7FNVsnu_n5mctGUQ4LX9Xh3PRnPfBPPfAZ4Y4SJcqEj12gpXK4D7erc1y5ikdTPEgzo7W0NJ1_i-Tw5PZVHfR93M1S7D0eSradut3Ui3jcYmSJKfellvkTXeh1uYLRLaDcujk_GLIv6Hfrjy99OmwSglqf_V298KRxdLZW8cl7ahqHDe_-1gPtwt0edbNaZyQO4ZstduHUwXPa2C3cu8RI-hPqo44HFZ8Z0mTEzsjp3TZusyllZbe2SNc1iPmNpN1itztE7sW1Rbxp3WXy3bDXU3TFqY2EXdq2JFPaiMKyv4cbfY1Sl-gi-HX78evDJ7S9ncI0I47VreIJ7P5Yp-og08yziQqmFzH0EeHFqotAi-NE81iFaQ2piL8ljYxG8YQaZJVaEj2GnrEr7FJiPKDFG15Hp3HArAq1FLj3ua0wWjYw8B7zhiSnTM5fTBRpL1WYwiVCdahWqVpFqVeLAu3HKqqPt-JvwBzKDUZAYt9sPqvpM9XpSYS6t1cLwjNq_Mi8xPAy04JrTlWpcOPCajEgRp0ZJRTtnetM06vPxQs0wJQtFLH3pwNteKK9wBUb3PRCoB6LhmkjuTSTRHMx0eLBV1TudRlFbMwI2hIQOvBqHaSYV0pW22pBMGCCsCz3uwJPOtMd1I9JHNOoHDsQTo58oZjpSFuctJbmIfETy-J37g-n__Ft_1Puzf5J-DreDdu9Erh_uwc663tgXcNNs10VTv2x9wA-WBFfv priority: 102 providerName: Springer Nature |
| Title | Production and characterization of novel ssRNA bacteriophage virus-like particles from metagenomic sequencing data |
| URI | https://link.springer.com/article/10.1186/s12951-019-0497-8 https://www.ncbi.nlm.nih.gov/pubmed/31084612 https://www.proquest.com/docview/2227181431 https://www.proquest.com/docview/2232021304 https://pubmed.ncbi.nlm.nih.gov/PMC6513524 https://doaj.org/article/3f9eea6c4d6546d08c432a64a4ce2a46 |
| Volume | 17 |
| WOSCitedRecordID | wos000468053400002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: Open Access: BioMedCentral Open Access Titles customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: M7P dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: KB. dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Health & Medical Collection customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLINK Contemporary 1997-Present customDbUrl: eissn: 1477-3155 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0022424 issn: 1477-3155 databaseCode: RSV dateStart: 20031201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYxgM88P0RGJVBSEigsHzayRNq0SYmoIo6mLYny3GcraJLStP27-fOcbNliL3wEqnxJant833Yd78j5K1iKi6ZjF0lU-ZGMpCuLH3pgi2S-0UCCt1Uazj-xsfj5OQkzeyGW2PDKjcy0Qjqola4R76HOZugjUDffZr_drFqFJ6u2hIaW2QHURJCE7qXdQ4Xpj7Yk0w_YXsN6LYYnWc8DkhBOPd0kYHs_1swX9FM16Mmrx2dGo10cP9_-_KA3LO2KB22zPOQ3NLVI3L3CkLhY7LIWkRYmD0qq4KqDt-5Td-kdUmreq1ntGkm4yHN28Z6fg5yiq6ni1Xjzqa_NJ1vIvAoJrTQC72UCA97MVXURnPD9yjGqz4hPw_2f3z-4toyDa5iIV-6KkpACvA0B2mRF54GCzGVLC19MPV4ruJQgxkkIy5D4ItccS8pudJgxoEvWSSahU_JdlVX-jmhPtiLHIRIIUsVaRZIycrUi3wJbqNKY88h3mbChLIY5lhKYyaML5Mw0c6xgDkWOMciccj77pF5C-BxE_EIuaAjROxtc6NenAk7TiIsU60lU1GBiWCFl6goDCSLZITF1SLmkDfIQwLRNSoM3zmTq6YRh0cTMQTnLGQ89VOHvLNEZQ09UNJmQ8A4ICBXj3K3RwnLX_WbNzwmrPhpxCWDOeR114xPYkhdpesV0oQBGHihFznkWcvZXb_B5ge71A8cwns83xuYfks1PTfg5Cz2waaHd37YrI7Lv_XPcX9xcydekjuBWbWx64e7ZHu5WOlX5LZaL6fNYkC2-Ak312RAdkb742wyMFsrcP06-jgwMgFassPv2Sn8mhwd_wGsd2Ze |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Zb9NAEB6VggQ8cB-GAgsCIYGs-lzbDwiFo2rUEEWloL4t6_W6tUjtECdB_Cl-IzO-WhfRtz7wmh3bmfG3c3jnAHiuuPJTLn1TyYibnnSkKVNbmuiLxHYSokGvpjV8HQXjcbi_H03W4HdbC0Npla1OrBR1Uij6Rr5JNZtojdDevZ39MGlqFJ2utiM0aljs6F8_MWQr3ww_4Pt94ThbH_feb5vNVAFTcTdYmMoLEbRBFCO448TS6NBEkkepjZ5JECvf1Wi1pRdIF9mIVWCFaaA0eh0Y-iSh5i7e9wJcRDfCCatUwUkX4FGpRXNyaod8s0Rb6lOwTscPERqDnu2rRgT8bQhOWMLTWZqnjmorC7h1_X-T3Q241vjabFBvjpuwpvNbcPVEB8bbMJ_UHW8RnUzmCVNd_-q6PJUVKcuLlZ6ystwdD1hcLxazQ9TDbJXNl6U5zb5rNmszDBkV7LAjvZDU_vYoU6zJVsfnMcrHvQNfzoXpu7CeF7m-D8xGfzhAJZnIVHmaO1LyNLI8W2JYrCLfMsBqASJU06OdRoVMRRWrhVzUmBKIKUGYEqEBr7pLZnWDkrOI3xHqOkLqLV79UMwPRCMn4aaR1pIrL6FCt8QKlec6knvSo-FxHjfgGWFWUPeQnNKTDuSyLMXw864YYPDp8iCyIwNeNkRpgRwo2VR7oByo4ViPcqNHiepN9ZdbTItGvZbiGNAGPO2W6UpKGcx1sSQa10EH1rU8A-7VO6njG2Ma9Lttx4Cgt8d6gumv5Nlh1Xyd-zbGLHjP1-1uPP5b_5T7g7OZeAKXt_c-jcRoON55CFecSmP4pu1uwPpivtSP4JJaLbJy_rjSNwy-nfcm_QO03Lj- |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3rb9MwED_BQDw-8BivwACDkJBA0fJwnPhjGVRMTFW1wbRvluM4W0WXVE3bv5-7vFjGQ0J8rc9tfTmffxff_Q7gjREmyoWOXKOlcLkOtKtzX7uIRVI_S_BAr7s1HB_Ek0lyciKnbZ_Tqst2764km5oGYmkqVruLLG-2eCJ2KzylIgqD6cW-RDd7Fa5x6hlE4frRcR9xUe1De5X522mDw6jm7P_VM184mi6nTV66O62PpPHd_17MPbjTolE2asznPlyxxTbc3OuawG3D7Qt8hQ9gOW34YfFZMl1kzPRsz00xJytzVpQbO2dVdTgZsbQZLBdn6LXYZrZcV-589t2yRZePx6i8hZ3blSay2POZYW1uN_4eo-zVh_Bt_Onr3me3bdrgGhHGK9fwBH1CLFP0HWnmWcSLUguZ-wj84tREoUVQpHmsQ7SS1MReksfGIqjDyDJLrAgfwVZRFvYJMB_RY4wuJdO54VYEWotcetzXGEQaGXkOeN3TU6ZlNKfGGnNVRzaJUI1qFapWkWpV4sC7fsqiofP4m_AHMolekJi46w_K5alq9aTCXFqrheEZlYVlXmJ4GGjBNadWa1w48JoMShHXRkHJPKd6XVVq_-hQjTBUC0UsfenA21YoL3EFRre1EagHoucaSO4MJNEczHC4s1vVOqNKUbkzAjmEig686odpJiXYFbZck0wYINwLPe7A48bM-3VjBIAo1Q8ciAcbYKCY4UgxO6upykXkI8LH73zfbYOff-uPen_6T9Iv4cb041gd7E--PINbQb2NItcPd2BrtVzb53DdbFazavmidg0_AKgXY7c |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Production+and+characterization+of+novel+ssRNA+bacteriophage+virus-like+particles+from+metagenomic+sequencing+data&rft.jtitle=Journal+of+nanobiotechnology&rft.au=Liekni%C5%86a%2C+Ilva&rft.au=Kalni%C5%86%C5%A1%2C+Gints&rft.au=Akopjana%2C+In%C4%81ra&rft.au=Bogans%2C+J%C4%81nis&rft.date=2019-05-13&rft.issn=1477-3155&rft.eissn=1477-3155&rft.volume=17&rft.issue=1&rft_id=info:doi/10.1186%2Fs12951-019-0497-8&rft.externalDBID=n%2Fa&rft.externalDocID=10_1186_s12951_019_0497_8 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-3155&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-3155&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-3155&client=summon |